News

This blog focuses academic-industrial relationships, what academic laboratories can learn from industrial experts. Read the other blogs for more insights.

This blog focuses Importance of cell and growth factor selection and how this can affect the future regulatory approval and future commercialization of academic research. Read the other blogs for more insights.

The panel discussion offered perspectives from companies working to bring cultivated meat, fish, fat and dairy to consumers. The aim was to inspire early career researchers and demystify research in this industry to highlight and encourage transitions in both directions between academia and industry. This blog focuses on the current regulatory frameworks and how the future of regulation may impact both industry and the future commercialization of academic research. Read the follow up blogs for more insights.

In this edition, we are excited to announce two new distributor agreements, our products will now be available in Türkiye and SLS will be making our products more accessible in the UK and Ireland. Our latest offer, buy 2 get 1 free and other news, the launch of our high quality food grade range.

‍Qkine, a leading manufacturer of high purity bioactive proteins, is pleased to announce its new sales distribution agreement with leading Turkish cell biology and stem cell reagent supplier Pitagen.

Qkine is pleased to announce a new UK & Ireland sales distribution agreement with SLS, the largest independent supplier of laboratory equipment, chemicals, and consumables in the UK.

Qkine are delighted that our eel FGF-2 proteins have elicited interest in Japan, recently the Nikkei Biotechnology & Business magazine have published an article focussing on the 145 and 154 amino acid versions of eel FGF-2, and the contribution Qkine species specific growth factors can have on the cultured seafood industry.

Qkine announces the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant growth factor supply chain for emerging sectors including cultivated meat, fish, fat and dairy.

NAPIC is a £38m centre dedicated to developing acceptable and planet-friendly alternatives to animal proteins led by researchers from the University of Leeds, James Hutton Institute, University of Sheffield and Imperial College London.

In this edition, we are excited to announce a price freeze moving into 2025, our win of Scale-up of the Year in the Cambridge Business Awards. We also share our latest hematopoietic stem cells blog, new products IL-2 and activin E PLUS and a new application note on growth factor stability.

As part of our commitment to supporting our customers and their science in economically difficult times, we have decided to hold our prices into 2025.

Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.

On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some […]

In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.

This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.